How Much Did Pharmright Raise?
Funding & Key Investors

Pharmright has secured significant enterprise-level funding, with a total capital infusion of $3M. The company recently announced a major strategic investment of $865K, underscoring its growth trajectory and market potential. This latest financing round follows a series of previous funding events, indicating sustained investor confidence in Pharmright's innovative approach to medication management.

What is Pharmright?

Pharmright
ManufacturingElectronicsMedical Devices & Equipment

Pharmright is developing the LiviPod, a comprehensive system designed for monitoring, reminding, and dispensing medications and supplements. This adaptable solution serves individuals managing their own health, caregivers overseeing loved ones, and those requiring assistance with supplement intake. The LiviPod system is modular, allowing for personalized medication management without subscription fees. Key features include real-time alerts, automated reminders, and an intuitive mobile application, all aimed at simplifying wellness routines and improving adherence to prescribed regimens.

How much funding has Pharmright raised?

Pharmright has raised a total of $3M across 3 funding rounds:

2014

Private Equity

$902K

2015

Series A

$1.2M

2016

Private Equity

$865K

Private Equity (2014): $902K, investors not publicly disclosed

Series A (2015): $1.2M led by SCRA Technology Ventures and Upstate Carolina Angel Network

Private Equity (2016): $865K, investors not publicly disclosed

Key Investors in Pharmright

SCRA Technology Ventures

SCRA Technology Ventures is an affiliate of SCRA, a public non-profit organization dedicated to fostering South Carolina's innovation economy through support for technology-based startups. They provide crucial funding, workspace, and resources to help companies like Pharmright grow.

Upstate Carolina Angel Network

The Upstate Carolina Angel Network is an angel investment group focused on providing capital and strategic guidance to early-stage companies in the region, supporting Pharmright's development.

What's next for Pharmright?

The recent major strategic investment in Pharmright signals a pivotal phase for the company, likely focused on scaling operations, expanding market reach, and further developing its LiviPod technology. This capital infusion is expected to accelerate product development and enhance distribution channels, positioning Pharmright to capture a larger share of the growing digital health and medication management market. The company's commitment to a subscription-free model may also serve as a key differentiator in attracting and retaining users.

See full Pharmright company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Chemicals & Related ProductsManufacturingBuilding MaterialsPlastic, Packaging & Containers
FurnitureManufacturing
ManufacturingTextiles & Apparel
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding Pharmright Financial Insights

What are the most recent funding rounds that Pharmright has completed, and what were the funding rounds?
Pharmright has recently completed 3 funding rounds: Private Equity on Apr 28, 2016, Series A on Jul 30, 2015, Private Equity on Nov 24, 2014.
What is the total amount of funding Pharmright has raised to date?
Pharmright has raised a total of $3M in funding to date.
How many funding rounds has Pharmright completed?
Pharmright has completed 3 funding rounds.
How much funding did Pharmright raise in its most recent funding round?
Pharmright raised $865K in its most recent funding round.
Which was the largest funding round in Pharmright's history?
The largest funding round in Pharmright's history was $1.2M.
See more information about Pharmright